CYP51 structure-based VNI scaffold development for treatment of human infections: Trypanosomatidae vs. the filamentous fungus Aspergillus fumigatus

Galina I. Lepesheva

Presentation information

Session

[Session 12] P450s and Drug Design

Sun. Jun 14, 2015 4:20 PM - 6:20 PM Hall B (1st Meeting Room 2F)

Chair:Toshiyuki Sakaki (Department of Biotechnology, Toyama Prefectural University)

[Session 12-2] CYP51 structure-based VNI scaffold development for treatment of human infections: Trypanosomatidae vs. the filamentous fungus Aspergillus fumigatus

^○Galina I. Lepesheva , Tatiana Y. Hargrove , Michael R. Waterman (Biochemistry, Vanderbilt University School of Medicine)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.
You can find the password on the inside front cover of the program book.